Cinclus Pharma Holding AB (publ)

kr 12.08As of Sun 8 Nov 2026, 12:00 UTC
STO:CINPHAHealthcare
Country Sweden
PE (Fwd) •••
TSR 2Y CAGR (32.95%)
Div yield —
ROE (79.92%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.05
PE TTM —
TSR TTM (26.34%)
Mkt cap kr 562.2M
ROIC (49.83%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 15
23.72%
(21.94%)
Hold 9|0|1|11|0
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.27
0.29
0.29
0.28
26.14%
28.60%
28.83%
13.89%
Revenuekr M
27.12
28.24
28.80
28.61
8.82%
8.12%
12.25%
6.24%
Peers (US$56.84M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.062
0.366
0.333
EBIT/Intx
5.837
0.883
0.949
Own earn%
176.15
(39.17)
(37.70)
Sh yield%
7.16
41.79
45.19
Owners
Insiders/Inst%
5.57
58.03
Short interest%
2.18
SBC / revenue%
1.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
19–24
$1 testx
—
Incr. ROIC%
7